Company Profile of Zhuhai HRD Pharmaceutical Co., Ltd.

Zhuhai HRD Pharmaceutical Co., Ltd. was founded in 2009 and is a pharmaceutical enterprise engaged in the research and development, production, and sales of pharmaceutical raw materials and intermediates. In April 2019, it invested 250 million yuan to start construction of a new GMP production base in the Gaolan Port National Chemical Park in Zhuhai, Guangdong. It was completed and put into operation in the first half of 2023, with an expected annual production capacity of 300 tons and a realized output value of 1 billion yuan. Our strengths: Park: National level chemical park with complete supporting facilities, stable production, and guaranteed supply. Scale: Covering an area of approximately 60 acres, with 9 GMP workshops and over 200 reaction vessels. The specifications of stainless steel and enamel reaction vessels range from 100L to 6000L, suitable for production in the kilogram to hundred kilogram range, meeting the requirements of pilot testing and scaling up. R&D: We have an independent R&D team, specializing in Grignard reaction, hydrogenation reaction, ultra-low temperature reaction (-80 °C), azide reaction and micro-channel nitration reaction etc. We can independently conduct quality research and registration applications for raw materials. Compliance: The GMP factory has a well-established quality management system, EHS system, and excellent professional team support. Drug Manufacturing Certificate was obtained in January 2024. Product list of APIs and its intermediates: Tedizolid Phosphate,Oseltamivir Phosphate，Fluvoxamine maleate, Ilaprazole, Vonoprozan Fumarate, Bilastine, Edoxaban (tosylate Monohydrate) , Finerenone, Relugolix , Elagolix Sodium, Indobufen, Flurbiprofen and their intermediates and so on.